Ghrelin, the peripheral hunger hormone

References

• Schwartz M. W., Woods S. C., Seeley R. J., Barsh G. S., Baskin D. G., Leibel R. L. Is the energy homeostasis system inherently biased toward weight gain?. Diabetes 2003; 52: 232–8
   PubMed Web of Science ®Google Scholar
• Zigman J. M., Elmquist J. K. Minireview: From anorexia to obesity—the yin and yang of body weight control. Endocrinology 2003; 144: 3749–56
   PubMed Web of Science ®Google Scholar
• Park A. J., Bloom S. R. Neuroendocrine control of food intake. Curr Opin Gastroenterol 2005; 21: 228–33
   PubMed Web of Science ®Google Scholar
• Korner J., Leibel R. L. To eat or not to eat—how the gut talks to the brain. N Eng J Med 2003; 349: 926–8
   PubMed Web of Science ®Google Scholar
• Small C. J., Bloom S. R. Gut hormones and the control of appetite. Trends Endocrinol Metab 2004; 15: 259–63
   PubMed Web of Science ®Google Scholar
• Marx J. Cellular warriors at the battle of the bulge. Science 2003; 299: 846–9
   PubMed Web of Science ®Google Scholar
• Gura T. Obesity drug pipeline not so fat. Science 2003; 299: 849–52
   PubMed Web of Science ®Google Scholar
• Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth‐hormone‐releasing acylated peptide from stomach. Nature 1999; 402: 656–60
   PubMed Web of Science ®Google Scholar
• Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M. S., Suganuma T., et al. Ghrelin, a novel growth hormone‐releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 141: 4255–61
   PubMed Web of Science ®Google Scholar
• Hou Z., Miao Y., Gao L., Pan H., Zhu S. Ghrelin‐containing neuron in cerebral cortex and hypothalamus linked with the DVC of brainstem in rat. Regul Pept 2006; 134: 126–31
   PubMedGoogle Scholar
• Gnanapavan S., Kola B., Bustin S. A., Morris D. G., McGee P., Fairclough P., et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS‐R, in humans. J Clin Endocrinol Metab 2002; 87: 2988–91
   PubMed Web of Science ®Google Scholar
• Zhang J. V., Ren P. G., Avsian‐Kretchmer O., Luo C. W., Rauch R., Klein C., et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005; 310: 996–9
   PubMed Web of Science ®Google Scholar
• Sun Y., Wang P., Zheng H., Smith R. G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 2004; 101: 4679–84
   PubMed Web of Science ®Google Scholar
• Zigman J. M., Nakano Y., Coppari R., Balthasar N., Marcus J. N., Lee C. E., et al. Mice lacking ghrelin receptors resist the development of diet‐induced obesity. J Clin Invest 2005; 115: 3564–72
   PubMed Web of Science ®Google Scholar
• Zigman J. M., Jones J. E., Lee C. E., Saper C. B., Elmquist J. K. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 2006; 494: 528–48
   PubMed Web of Science ®Google Scholar
• Kojima M., Kangawa K. Ghrelin: structure and function. Physiol Rev 2005; 85: 495–522
   PubMed Web of Science ®Google Scholar
• Ghigo E., Broglio F., Arvat E., Maccario M., Papotti M., Muccioli G. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol (Oxf) 2005; 62: 1–17
   PubMed Web of Science ®Google Scholar
• Korbonits M., Goldstone A. P., Gueorguiev M., Grossman A. B. Ghrelin—a hormone with multiple functions. Front Neuroendocrinol 2004; 25: 27–68
   PubMed Web of Science ®Google Scholar
• Tena‐Sempere M. Exploring the role of ghrelin as novel regulator of gonadal function. Growth Horm IGF Res 2005; 15: 83–8
   Google Scholar
• Hosoda H., Kojima M., Kangawa K. Biological, physiological, and pharmacological aspects of ghrelin. J Pharmacol Sci 2006; 100: 398–410
   PubMed Web of Science ®Google Scholar
• Arvat E., Maccario M., Di Vito L., Broglio F., Benso A., Gottero C., et al. Endocrine activities of ghrelin, a natural GH secretagogue, in humans: comparison and interactions with hexarelin, a non natural peptidyl GHS, and GH‐releasing hormone. J Clin Endocrinol Metab 2001; 86: 1169–74
   PubMed Web of Science ®Google Scholar
• Tschöp M., Smiley D. L., Heiman M. L. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908–13
   PubMed Web of Science ®Google Scholar
• Tebbe J. J., Mronga S., Tebbe C. G., Ortmann E., Arnold R., Schafer M. K. Ghrelin‐induced stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Y1‐ and corticotrophin‐releasing factor 1 receptor activation. J Neuroendocrinol 2005; 17: 570–6
   PubMedGoogle Scholar
• Gauna C., Delhanty P. J., Hofland L. J., Janssen J. A., Broglio F., Ross R. J., et al. Ghrelin stimulates, whereas des‐octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab 2005; 90: 1055–60
   PubMed Web of Science ®Google Scholar
• Muccioli G., Pons N., Ghe C., Catapano F., Granata R., Ghigo E. Ghrelin and des‐acyl ghrelin both inhibit isoproterenol‐induced lipolysis in rat adipocytes via a non‐type 1a growth hormone secretagogue receptor. Eur J Pharmacol 2004; 498: 27–35
   PubMed Web of Science ®Google Scholar
• Cao J. M., Ong H., Chen C. Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system. Trends Endocrinol Metab 2006; 17: 13–18
   PubMedGoogle Scholar
• Henriques‐Coelho T., Roncon‐Albuquerque J. R., Lourenco A. P., Baptista M. J., Oliveira S. M., Brandao‐Nogueira A., et al. Ghrelin reverses molecular, structural and hemodynamic alterations of the right ventricle in pulmonary hypertension. Rev Port Cardiol 2006; 25: 55–63
   PubMedGoogle Scholar
• Tesauro M., Schinzari F., Iantorno M., Rizza S., Melina D., Lauro D., et al. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation 2005; 112: 2986–92
   PubMed Web of Science ®Google Scholar
• Rudd J. A., Ngan M. P., Wai M. K., King A. G., Witherington J., Andrews P. L., et al. Anti‐emetic activity of ghrelin in ferrets exposed to the cytotoxic anti‐cancer agent cisplatin. Neurosci Lett 2006; 392: 79–83
   PubMed Web of Science ®Google Scholar
• Brunetti L., Recinella L., Orlando G., Michelotto B., Di Nisio C., Vacca M. Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus. Eur J Pharmacol 2002; 454: 189–92
   Google Scholar
• Dixit V. D., Taub D. D. Ghrelin and immunity: A young player in an old field. Exp Gerontol 2005; 40: 900–10
   PubMed Web of Science ®Google Scholar
• Yada T., Kaiya H., Mutoh K., Azuma T., Hyodo S., Kangawa K. Ghrelin stimulates phagocytosis and superoxide production in fish leukocytes. J Endocrinol 2006; 189: 57–65
   Google Scholar
• Takeda R., Nishimatsu H., Suzuki E., Satonaka H., Nagata D., Oba S., et al. Ghrelin improves renal function in mice with ischemic acute renal failure. J Am Soc Nephrol 2006; 17: 113–21
   PubMed Web of Science ®Google Scholar
• Konturek P. C., Brzozowski T., Pajdo R., Nikiforuk A., Kwiecien S., Harsch I., et al. Ghrelin‐a new gastroprotective factor in gastric mucosa. J Physiol Pharmacol 2004; 55: 325–36
   PubMed Web of Science ®Google Scholar
• Granado M., Priego T., Martin A. I., Villanua M. A., Lopez‐Calderon A. Anti‐inflammatory effect of the ghrelin agonist growth hormone‐releasing peptide‐2 (GHRP‐2) in arthritic rats. Am J Physiol Endocrinol Metab 2005; 288: E486–92
   Web of Science ®Google Scholar
• Wu R., Dong W., Zhou M., Cui X., Hank S. H., Wang P. Ghrelin improves tissue perfusion in severe sepsis via downregulation of endothelin‐1. Cardiovasc Res 2005; 68: 318–26
   PubMed Web of Science ®Google Scholar
• Fukushima N., Hanada R., Teranishi H., Fukue Y., Tachibana T., Ishikawa H., et al. Ghrelin directly regulates bone formation. J Bone Miner Res 2005; 20: 790–8
   PubMed Web of Science ®Google Scholar
• Caminos J. E., Gualillo O., Lago F., Otero M., Blanco M., Gallego R., et al. The endogenous growth hormone secretagogue (ghrelin) is synthesized and secreted by chondrocytes. Endocrinology 2005; 146: 1285–92
   PubMedGoogle Scholar
• Matsuda K., Miura T., Kaiya H., Maruyama K., Uchiyama M., Kangawa K., et al. Stimulatory effect of n‐octanoylated ghrelin on locomotor activity in the goldfish, Carassius auratus. Peptides 2006; 27: 1335–40
   Google Scholar
• Jaszberenyi M., Bujdoso E., Bagosi Z., Telegdy G. Mediation of the behavioral, endocrine and thermoregulatory actions of ghrelin. Horm Behav 2006; 50: 266–73
   PubMedGoogle Scholar
• Tang‐Christensen M., Vrang N., Ortmann S., Bidlingmaier M., Horvath T. L., Tschop M. Central Administration of Ghrelin and Agouti‐Related Protein (83‐132) Increases Food Intake and Decreases Spontaneous Locomotor Activity in Rats. Endocrinology 2004; 145: 4645–52
   PubMed Web of Science ®Google Scholar
• Diano S., Farr S. A., Benoit S. C., McNay E. C., da Silva I., Horvath B., et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 2006; 9: 381–8
   PubMed Web of Science ®Google Scholar
• Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., et al. A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194–8
   PubMed Web of Science ®Google Scholar
• Cummings D. E., Purnell J. Q., Frayo R. S., Schmidova K., Wisse B. E., Weigle D. S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714–19
   PubMed Web of Science ®Google Scholar
• Cummings D. E., Weigle D. S., Frayo R. S., Breen P. A., Ma M. K., Dellinger E. P., et al. Plasma ghrelin levels after diet‐induced weight loss or gastric bypass surgery. N Eng J Med 2002; 346: 1623–30
   PubMed Web of Science ®Google Scholar
• Drazen D. L., Vahl T. P., D'Alessio D. A., Seeley R. J., Woods S. C. Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status. Endocrinology 2006; 147: 23–30
   PubMed Web of Science ®Google Scholar
• Iqbal J., Kurose Y., Canny B., Clarke I. J. Effects of central infusion of ghrelin on food intake and plasma levels of growth hormone, luteinizing hormone, prolactin, and cortisol secretion in sheep. Endocrinology 2006; 147: 510–19
   Google Scholar
• Egecioglu E., Bjursell M., Ljungberg A., Dickson S. L., Kopchick J. J., Bergstrom G., et al. Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice. Am J Physiol Endocrinol Metab 2006; 290: E317–25
   Google Scholar
• Wortley K. E., Anderson K. D., Garcia K., Murray J. D., Malinova L., Liu R., et al. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 2004; 101: 8227–32
   PubMed Web of Science ®Google Scholar
• Wren A. M., Small C. J., Ward H. L., Murphy K. G., Dakin C. L., Taheri S., et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000; 141: 4325–8
   PubMed Web of Science ®Google Scholar
• Tschöp M., Weyer C., Tataranni P. A., Devanarayan V., Ravussin E., Heiman M. L. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707–09
   PubMed Web of Science ®Google Scholar
• Masuda Y., Tanaka T., Inomata N., Ohnuma N., Tanaka S., Itoh Z., et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 2000; 276: 905–08
   PubMed Web of Science ®Google Scholar
• Peeters T. L. Central and peripheral mechanisms by which ghrelin regulates gut motility. J Physiol Pharmacol 2003; 54 Suppl 4: 95–103
   PubMedGoogle Scholar
• Inui A., Asakawa A., Bowers C. Y., Mantovani G., Laviano A., Meguid M. M., et al. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J 2004; 18: 439–56
   PubMed Web of Science ®Google Scholar
• Ohno T., Kamiyama Y., Aihara R., Nakabayashi T., Mochiki E., Asao T., et al. Ghrelin does not stimulate gastrointestinal motility and gastric emptying: an experimental study of conscious dogs. Neurogastroenterol Motil 2006; 18: 129–35
   Google Scholar
• Tack J., Depoortere I., Bisschops R., Verbeke K., Janssens J., Peeters T. Influence of ghrelin on gastric emptying and meal‐related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther 2005; 22: 847–53
   PubMed Web of Science ®Google Scholar
• Sun Y., Ahmed S., Smith R. G. Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 2003; 23: 7973–81
   PubMed Web of Science ®Google Scholar
• Wortley K. E., Del Rincon J. P., Murray J. D., Garcia K., Iida K., Thorner M. O., et al. Absence of ghrelin protects against early‐onset obesity. J Clin Invest 2005; 115: 3573–8
   PubMed Web of Science ®Google Scholar
• De Smet B., Depoortere I., Moechars D., Swennen Q., Moreaux B., Cryns K., et al. Energy homeostasis and gastric emptying in ghrelin knockout mice. J Pharmacol Exp Ther 2006; 316: 431–9
   PubMed Web of Science ®Google Scholar
• Shearman L. P., Wang S. P., Helmling S., Stribling D. S., Mazur P., Ge L., et al. Ghrelin neutralization by a ribonucleic acid‐SPM ameliorates obesity in diet‐induced obese mice. Endocrinology 2006; 147: 1517–26
   PubMed Web of Science ®Google Scholar
• Vizcarra J. A., Kirby J. D., Kim S. K., Galyean M. L. Active immunization against ghrelin decreases weight gain and alters plasma concentrations of growth hormone in growing pigs. Domest Anim Endocrinol 2006 Jun 8, [Epub ahead of print]
   Google Scholar
• Ariyasu H., Takaya K., Iwakura H., Hosoda H., Akamizu T., Arai Y., et al. Transgenic mice overexpressing des‐acyl ghrelin show small phenotype. Endocrinology 2005; 146: 355–64
   Google Scholar
• Wei W., Qi X., Reed J., Ceci J., Wang H. Q., Wang G., et al. Effect of chronic hyperghrelinemia on ingestive action of ghrelin. Amer J Physiol Regul Integr Comp Physiol 2006; 290: R803–08
   Google Scholar
• Sun Y., Asnicar M., Saha P. K., Chan L., Smith R. G. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 2006; 3: 379–86
   PubMed Web of Science ®Google Scholar
• Asakawa A., Inui A., Kaga T., Katsuura G., Fujimiya M., Fujino M. A., et al. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 2003; 52: 947–52
   PubMed Web of Science ®Google Scholar
• Shuto Y., Shibasaki T., Otagiri A., Kuriyama H., Ohata H., Tamura H., et al. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 2002; 109: 1429–36
   PubMed Web of Science ®Google Scholar
• Wortley K. E., Anderson K., Garcia K., Murray J., Malinova L., Liu R., et al. Deletion of ghrelin reveals no effect on food intake, but a primary role in energy balance. Obes Res 2004; 12: 170
   Google Scholar
• Luquet S., Perez F. A., Hnasko T. S., Palmiter R. D. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 2005; 310: 683–5
   PubMed Web of Science ®Google Scholar
• Gropp E., Shanabrough M., Borok E., Xu A. W., Janoschek R., Buch T., et al. Agouti‐related peptide‐expressing neurons are mandatory for feeding. Nat Neurosci 2005; 8: 1289–91
   PubMed Web of Science ®Google Scholar
• Ste M. L., Luquet S., Cole T. B., Palmiter R. D. Modulation of neuropeptide Y expression in adult mice does not affect feeding. Proc Natl Acad Sci USA 2005; 102: 18632–7
   Google Scholar
• Bewick G. A., Gardiner J. V., Dhillo W. S., Kent A. S., White N. E., Webster Z., et al. Postembryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J 2005; 19: 1680–2
   PubMed Web of Science ®Google Scholar
• Nogueiras R., Tschop M. Biomedicine. Separation of conjoined hormones yields appetite rivals. Science 2005; 310: 985–6
   Google Scholar
• Ukkola O., Ravussin E., Jacobson P., Snyder E. E., Chagnon M., Sjostrom L., et al. Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J Clin Endocrinol Metab 2001; 86: 3996–9
   Google Scholar
• Hinney A., Hoch A., Geller F., Schafer H., Siegfried W., Goldschmidt H., et al. Ghrelin gene: identification of missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students. J Clin Endocrinol Metab 2002; 87: 2716–19
   PubMed Web of Science ®Google Scholar
• Ukkola O., Ravussin E., Jacobson P., Perusse L., Rankinen T., Tschöp M., et al. Role of ghrelin polymorphisms in obesity based on three different studies. Obes Res 2002; 10: 782–91
   PubMedGoogle Scholar
• Vivenza D., Rapa A., Castellino N., Bellone S., Petri A., Vacca G., et al. Ghrelin gene polymorphisms and ghrelin, insulin, IGF‐I, leptin and anthropometric data in children and adolescents. Eur J Endocrinol 2004; 151: 127–33
   PubMed Web of Science ®Google Scholar
• Korbonits M., Gueorguiev M., O'Grady E., Lecoeur C., Swan D. C., Mein C. A., et al. A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. J Clin Endocrinol Metab 2002; 87: 4005–08
   PubMed Web of Science ®Google Scholar
• Miraglia D. G., Santoro N., Cirillo G., Raimondo P., Grandone A., D'Aniello A., et al. Molecular screening of the ghrelin gene in Italian obese children: the Leu72Met variant is associated with an earlier onset of obesity. Int J Obes Relat Metab Disord 2004; 28: 447–50
   PubMedGoogle Scholar
• Jo D. S., Kim S. L., Kim S. Y., Hwang P. H., Lee K. H., Lee D. Y. Preproghrelin Leu72Met polymorphism in obese Korean children. J Pediatr Endocrinol Metab 2005; 18: 1083–6
   PubMed Web of Science ®Google Scholar
• Bing C., Ambye L., Fenger M., Jorgensen T., Borch‐Johnsen K., Madsbad S., et al. Large‐scale studies of the Leu72Met polymorphism of the ghrelin gene in relation to the metabolic syndrome and associated quantitative traits. Diabet Med 2005; 22: 1157–60
   Google Scholar
• Steinle N. I., Pollin T. I., O'Connell J. R., Mitchell B. D., Shuldiner A. R. Variants in the ghrelin gene are associated with metabolic syndrome in the Old Order Amish. J Clin Endocrinol Metab 2005; 90: 6672–7
   PubMed Web of Science ®Google Scholar
• Vartiainen J., Kesaniemi Y. A., Ukkola O. Sequencing analysis of ghrelin gene 5′ flanking region: relations between the sequence variants, fasting plasma total ghrelin concentrations, and body mass index. Metabolism 2006; 55: 1420–5
   Google Scholar
• Bittel D. C., Kibiryeva N., Dasouki M., Knoll J. H., Butler M. G. A 9‐year‐old male with a duplication of chromosome 3p25.3p26.2: Clinical report and gene expression analysis. Am J Med Genet A 2006; 140: 573–9
   Google Scholar
• Baessler A., Hasinoff M. J., Fischer M., Reinhard W., Sonnenberg G. E., Olivier M., et al. Genetic linkage and association of the growth hormone secretagogue receptor (ghrelin receptor) gene in human obesity. Diabetes 2005; 54: 259–67
   PubMed Web of Science ®Google Scholar
• Wang H. J., Geller F., Dempfle A., Schauble N., Friedel S., Lichtner P., et al. Ghrelin receptor gene: identification of several sequence variants in extremely obese children and adolescents, healthy normal‐weight and underweight students, and children with short normal stature. J Clin Endocrinol Metab 2004; 89: 157–62
   PubMed Web of Science ®Google Scholar
• Cellini E., Nacmias B., Brecelj‐Anderluh M., Badia‐Casanovas A., Bellodi L., Boni C., et al. Case‐control and combined family trios analysis of three polymorphisms in the ghrelin gene in European patients with anorexia and bulimia nervosa. Psychiatr Genet 2006; 16: 51–2
   PubMed Web of Science ®Google Scholar
• Monteleone P., Tortorella A., Castaldo E., Di Filippo C., Maj M. No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene with anorexia nervosa or bulimia nervosa. Neurosci Lett 2006; 398: 325–7
   PubMed Web of Science ®Google Scholar
• Miyasaka K., Hosoya H., Sekime A., Ohta M., Amono H., Matsushita S., et al. Association of ghrelin receptor gene polymorphism with bulimia nervosa in a Japanese population. J Neural Transm 2006; 113: 1279–85
   PubMed Web of Science ®Google Scholar
• Ando T., Komaki G., Naruo T., Okabe K., Takii M., Kawai K., et al. Possible role of preproghrelin gene polymorphisms in susceptibility to bulimia nervosa. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 929–34
   Web of Science ®Google Scholar
• Mager U., Kolehmainen M., Lindstrom J., Eriksson J. G., Valle T. T., Hamalainen H., et al. Association between ghrelin gene variations and blood pressure in subjects with impaired glucose tolerance. Am J Hypertens 2006; 19: 920–6
   Google Scholar
• Pöykkö S. M., Ukkola O., Kauma H., Savolainen M. J., Kesäniemi Y. A. Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle‐aged subjects. Diabetologia 2003; 46: 455–8
   PubMed Web of Science ®Google Scholar
• Larsen L. H., Gjesing A. P., Sorensen T. I., Hamid Y. H., Echwald S. M., Toubro S., et al. Mutation analysis of the preproghrelin gene: no association with obesity and type 2 diabetes. Clin Biochem 2005; 38: 420–4
   Google Scholar
• Choi H. J., Cho Y. M., Moon M. K., Choi H. H., Shin H. D., Jang H. C., et al. Polymorphisms in the Ghrelin Gene Are Associated with Serum High‐Density Lipoprotein Cholesterol Level and not with Type 2 Diabetes Mellitus in Koreans. J Clin Endocrinol Metab 2006; 91: 4657–63
   Google Scholar
• Vartiainen J., Poykko S. M., Raisanen T., Kesaniemi Y. A., Ukkola O. Sequencing analysis of the ghrelin receptor (growth hormone secretagogue receptor type 1a) gene. Eur J Endocrinol 2004; 150: 457–63
   Google Scholar
• Ukkola O., Kesäniemi Y. A. Preproghrelin Leu72Met polymorphism in patients with type 2 diabetes mellitus. J Intern Med 2003; 254: 391–4
   Google Scholar
• Kim S. Y., Jo D. S., Hwang P. H., Park J. H., Park S. K., Yi H. K., et al. Preproghrelin Leu72Met polymorphism is not associated with type 2 diabetes mellitus. Metabolism 2006; 55: 366–70
   PubMed Web of Science ®Google Scholar
• Lee D. Y., Kim S. Y., Jo D. S., Hwang P. H., Kang K. P., Lee S., et al. Preproghrelin Leu72Met polymorphism predicts a lower rate of developing renal dysfunction in type 2 diabetic nephropathy. Eur J Endocrinol 2006; 155: 187–90
   Google Scholar
• Baessler A., Kwitek A. E., Fischer M., Koehler M., Reinhard W., Erdmann J., et al. Association of the Ghrelin receptor gene region with left ventricular hypertrophy in the general population: results of the MONICA/KORA Augsburg Echocardiographic Substudy. Hypertension 2006; 47: 920–7
   Google Scholar
• Wiltshire S., Frayling T. M., Hattersley A. T., Hitman G. A., Walker M., Levy J. C., et al. Evidence for linkage of stature to chromosome 3p26 in a large U.K. family data set ascertained for type 2 diabetes. Am J Hum Genet 2002; 70: 543–6
   Google Scholar
• Pöykkö S. M., Ukkola O., Kauma H., Kellokoski E., Horkko S., Kesaniemi Y. A. The negative association between plasma ghrelin and IGF‐I is modified by obesity, insulin resistance and type 2 diabetes. Diabetologia 2005; 48: 309–16
   PubMedGoogle Scholar
• Pantel J., Legendre M., Cabrol S., Hilal L., Hajaji Y., Morisset S., et al. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest 2006; 116: 760–8
   PubMed Web of Science ®Google Scholar
• Hosoda H., Kojima M., Matsuo H., Kangawa K. Purification and characterization of rat des‐Gln14‐Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J Biol Chem 2000; 275: 21995–2000
   PubMedGoogle Scholar
• Delhanty P. J., van der Eerden B. C., van der Velde M., Gauna C., Pols H. A., Jahr H., et al. Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen‐activated protein kinase (MAPK)/phosphoinositide 3‐kinase (PI3K) pathways in the absence of GHS‐R1a. J Endocrinol 2006; 188: 37–47
   Google Scholar
• Broglio F., Gottero C., Prodam F., Gauna C., Muccioli G., Papotti M., et al. Non‐acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab 2004; 89: 3062–5
   PubMed Web of Science ®Google Scholar
• Gauna C., Meyler F. M., Janssen J. A., Delhanty P. J., Abribat T., van Koetsveld P., et al. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab 2004; 89: 5035–42
   PubMed Web of Science ®Google Scholar
• Chen C. Y., Chao Y., Chang F. Y., Chien E. J., Lee S. D., Doong M. L. Intracisternal des‐acyl ghrelin inhibits food intake and non‐nutrient gastric emptying in conscious rats. Int J Mol Med 2005; 16: 695–9
   PubMedGoogle Scholar
• Chen C. Y., Inui A., Asakawa A., Fujino K., Kato I., Chen C. C., et al. Des‐acyl Ghrelin Acts by CRF Type 2 Receptors to Disrupt Fasted Stomach Motility in Conscious Rats. Gastroenterology 2005; 129: 8–25
   PubMed Web of Science ®Google Scholar
• Toshinai K., Yamaguchi H., Sun Y., Smith R. G., Yamanaka A., Sakurai T., et al. Des‐acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 2006; 147: 2306–14
   PubMed Web of Science ®Google Scholar
• Nanzer A. M., Khalaf S., Mozid A. M., Fowkes R. C., Patel M. V., Burrin J. M., et al. Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen‐activated protein kinase pathway. Eur J Endocrinol 2004; 151: 233–40
   PubMedGoogle Scholar
• Thompson N. M., Gill D. A., Davies R., Loveridge N., Houston P. A., Robinson I. C., et al. Ghrelin and des‐octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of GHS‐R1a. Endocrinology 2004; 145: 232–42
   Google Scholar
• Bedendi I., Alloatti G., Marcantoni A., Malan D., Catapano F., Ghe C., et al. Cardiac effects of ghrelin and its endogenous derivatives des‐octanoyl ghrelin and des‐Gln(14)‐ghrelin. Eur J Pharmacol 2003; 476: 87–95
   PubMed Web of Science ®Google Scholar
• Baldanzi G., Filigheddu N., Cutrupi S., Catapano F., Bonissoni S., Fubini A., et al. Ghrelin and des‐acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3‐kinase/AKT. J Cell Biol 2002; 159: 1029–37
   PubMed Web of Science ®Google Scholar
• Cassoni P., Papotti M., Ghe C., Catapano F., Sapino A., Graziani A., et al. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab 2001; 86: 1738–45
   PubMed Web of Science ®Google Scholar
• Asakawa A., Inui A., Fujimiya M., Sakamaki R., Shinfuku N., Ueta Y., et al. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 2005; 54: 18–24
   PubMed Web of Science ®Google Scholar
• Kleinz M. J., Maguire J. J., Skepper J. N., Davenport A. P. Functional and immunocytochemical evidence for a role of ghrelin and des‐octanoyl ghrelin in the regulation of vascular tone in man. Cardiovasc Res 2006; 69: 227–35
   PubMed Web of Science ®Google Scholar
• Heijboer A. C., van den Hoek A. M., Parlevliet E. T., Havekes L. M., Romijn J. A., Pijl H., et al. Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice. Diabetologia 2006; 49: 732–8
   PubMed Web of Science ®Google Scholar
• Neary N. M., Druce M. R., Small C. J., Bloom S. R. Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect. Gut 2006; 55: 135
   PubMedGoogle Scholar
• Horvath T. L., Diano S., Sotonyi P., Heiman M., Tschöp M. Minireview: ghrelin and the regulation of energy balance—a hypothalamic perspective. Endocrinology 2001; 142: 4163–9
   PubMed Web of Science ®Google Scholar
• Banks W. A., Tschöp M., Robinson S. M., Heiman M. L. Extent and direction of ghrelin transport across the blood‐brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 2002; 302: 822–7
   PubMed Web of Science ®Google Scholar
• Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., et al. The role of the gastric afferent vagal nerve in ghrelin‐induced feeding and growth hormone secretion in rats. Gastroenterology 2002; 123: 1120–8
   PubMed Web of Science ®Google Scholar
• Lawrence C. B., Snape A. C., Baudoin F. M., Luckman S. M. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology 2002; 143: 155–62
   PubMed Web of Science ®Google Scholar
• Dickson S. L., Luckman S. M. Induction of c‐fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)‐releasing factor neurones in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH‐releasing peptide‐6. Endocrinology 1997; 138: 771–7
   PubMed Web of Science ®Google Scholar
• Riediger T., Traebert M., Schmid H. A., Scheel C., Lutz T. A., Scharrer E. Site‐specific effects of ghrelin on the neuronal activity in the hypothalamic arcuate nucleus. Neurosci Lett 2003; 341: 151–5
   Web of Science ®Google Scholar
• Chen H. Y., Trumbauer M. E., Chen A. S., Weingarth D. T., Adams J. R., Frazier E. G., et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y (NPY) and agouti‐related protein (AgRP). Endocrinology 2004; 145: 2607–12
   PubMed Web of Science ®Google Scholar
• Tschöp M., Statnick M. A., Suter T. M., Heiman M. L. GH‐Releasing peptide‐2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti‐related protein. Endocrinology 2002; 143: 558–68
   PubMed Web of Science ®Google Scholar
• Qian S., Chen H., Weingarth D., Trumbauer M. E., Novi D. E., Guan X., et al. Neither agouti‐related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol 2002; 22: 5027–35
   PubMed Web of Science ®Google Scholar
• Andersson U., Filipsson K., Abbott C. R., Woods A., Smith K., Bloom S. R., et al. AMP‐activated protein kinase plays a role in the control of food intake. J Biol Chem 2004; 279: 12005–08
   PubMed Web of Science ®Google Scholar
• Kola B., Hubina E., Tucci S. A., Kirkham T. C., Garcia E. A., Mitchell S. E., et al. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP‐activated protein kinase. J Biol Chem 2005; 280: 25196–201
   PubMed Web of Science ®Google Scholar
• Halem H. A., Taylor J. E., Dong J. Z., Shen Y., Datta R., Abizaid A., et al. Novel analogs of ghrelin: physiological and clinical implications. Eur J Endocrinol 2004; 151 Suppl 2: S071–5
   Google Scholar
• Halem H. A., Taylor J. E., Dong J. Z., Shen Y., Datta R., Abizaid A., et al. A novel growth hormone secretagogue‐1a receptor antagonist that blocks ghrelin‐induced growth hormone secretion but induces increased body weight gain. Neuroendocrinol 2005; 81: 339–49
   PubMed Web of Science ®Google Scholar
• Zizzari P., Halem H., Taylor J., Dong J. Z., Datta R., Culler M. D., et al. Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH Pulse amplitude: evidence from antagonism of the GH secretagogue‐R1a receptor. Endocrinology 2005; 146: 3836–42
   Google Scholar
• Shintani M., Ogawa Y., Ebihara K., Aizawa‐Abe M., Miyanaga F., Takaya K., et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001; 50: 227–32
   PubMed Web of Science ®Google Scholar
• Ueno N., Dube M. G., Inui A., Kalra P. S., Kalra S. P. Leptin modulates orexigenic effects of ghrelin, attenuates adiponectin and insulin levels, and selectively the dark‐phase feeding as revealed by central leptin gene therapy. Endocrinology 2004; 145: 4176–84
   PubMed Web of Science ®Google Scholar
• Chan J. L., Bullen J., Lee J. H., Yiannakouris N., Mantzoros C. S. Ghrelin levels are not regulated by recombinant leptin administration and/or three days of fasting in healthy subjects. J Clin Endocrinol Metab 2004; 89: 335–43
   PubMed Web of Science ®Google Scholar
• Natalucci G., Riedl S., Gleiss A., Zidek T., Frisch H. Spontaneous 24‐h ghrelin secretion pattern in fasting subjects: maintenance of a meal‐related pattern. Eur J Endocrinol 2005; 152: 845–50
   PubMed Web of Science ®Google Scholar
• Caixas A., Bashore C., Nash W., Pi‐Sunyer F., Laferrere B. Insulin, unlike food intake, does not suppress ghrelin in human subjects. J Clin Endocrinol Metab 2002; 87: 1902–06
   PubMed Web of Science ®Google Scholar
• Murdolo G., Lucidi P., Di Loreto C., Parlanti N., De Cicco A., Fatone C., et al. Insulin is Required for Prandial Ghrelin Suppression in Humans. Diabetes 2003; 52: 2923–7
   PubMed Web of Science ®Google Scholar
• Flanagan D. E., Evans M. L., Monsod T. P., Rife F., Heptulla R. A., Tamborlane W. V., et al. The influence of insulin on circulating ghrelin. Am J Physiol Endocrinol Metab 2003; 284: E313–16
   PubMed Web of Science ®Google Scholar
• Nakagawa E., Nagaya N., Okumura H., Enomoto M., Oya H., Ono F., et al. Hyperglycaemia suppresses the secretion of ghrelin, a novel growth‐ hormone‐releasing peptide: responses to the intravenous and oral administration of glucose. Clin Sci (Lond) 2002; 103: 325–8
   PubMed Web of Science ®Google Scholar
• Saad M. F., Bernaba B., Hwu C. M., Jinagouda S., Fahmi S., Kogosov E., et al. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 2002; 87: 3997–4000
   PubMed Web of Science ®Google Scholar
• Coiro V., Volpi R., Capretti L., Caffarri G., Colla R., Chiodera P. Effects of pyridostigmine and naloxone on the abnormal TSH response to TRH during starvation in humans. J Investig Med 1999; 47: 227–31
   Google Scholar
• Stoving R. K., Andersen M., Flyvbjerg A., Frystyk J., Hangaard J., Vinten J., et al. Indirect evidence for decreased hypothalamic somatostatinergic tone in anorexia nervosa. Clin Endocrinol (Oxf) 2002; 56: 391–6
   Google Scholar
• Thuesen B., Schaffalitzky de Muckadell O. B., Holst J. J., Bahnsen M. The relationship of secretin and somatostatin levels in plasma to glucose administration and acid secretion during fasting. Am J Gastroenterol 1987; 82: 723–6
   PubMed Web of Science ®Google Scholar
• Hirsh D., Heinrichs C., Leenders B., Wong A. C., Cummings D. E., Chanoine J. P. Ghrelin Is Suppressed by Glucagon and Does Not Mediate Glucagon‐Related Growth Hormone Release. Horm Res 2005; 63: 111–18
   Google Scholar
• Arafat M. A., Otto B., Rochlitz H., Tschop M., Bahr V., Mohlig M., et al. Glucagon inhibits ghrelin secretion in humans. Eur J Endocrinol 2005; 153: 397–402
   Google Scholar
• Arafat A. M., Perschel F. H., Otto B., Weickert M. O., Rochlitz H., Schofl C., et al. Glucagon suppression of ghrelin secretion is exerted at hypothalamus‐pituitary level. J Clin Endocrinol Metab 2006; 91: 3528–33
   Google Scholar
• Sugino T., Yamaura J., Yamagishi M., Ogura A., Hayashi R., Kurose Y., et al. A transient surge of ghrelin secretion before feeding is modified by different feeding regimens in sheep. Biochem Biophys Res Commun 2002; 298: 785–8
   Google Scholar
• Sugino T., Hasegawa Y., Kikkawa Y., Yamaura J., Yamagishi M., Kurose Y., et al. A transient ghrelin surge occurs just before feeding in a scheduled meal‐fed sheep. Biochem Biophys Res Commun 2002; 295: 255–60
   PubMed Web of Science ®Google Scholar
• Williams D. L., Cummings D. E., Grill H. J., Kaplan J. M. Meal‐related ghrelin suppression requires postgastric feedback. Endocrinology 2003; 144: 2765–7
   PubMed Web of Science ®Google Scholar
• Broglio F., Gottero C., van Koetsveld P., Prodam F., Destefanis S., Benso A., et al. Acetylcholine regulates ghrelin secretion in humans. J Clin Endocrinol Metab 2004; 89: 2429–33
   PubMed Web of Science ®Google Scholar
• Williams D. L., Grill H. J., Cummings D. E., Kaplan J. M. Vagotomy dissociates short‐ and long‐term controls of circulating ghrelin. Endocrinology 2003; 144: 5184–7
   PubMed Web of Science ®Google Scholar
• Lee H. M., Wang G., Englander E. W., Kojima M., Greeley J. G., Jr. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 2002; 143: 185–90
   PubMed Web of Science ®Google Scholar
• Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Ueno N., et al. Ghrelin is an appetite‐stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001; 120: 337–45
   PubMed Web of Science ®Google Scholar
• Maier C., Schaller G., Buranyi B., Nowotny P., Geyer G., Wolzt M., et al. The cholinergic system controls ghrelin release and ghrelin‐induced growth hormone release in humans. J Clin Endocrinol Metab 2004; 89: 4729–33
   Google Scholar
• Le Roux C. W., Neary N. M., Halsey T. J., Small C. J., Martinez‐Isla A. M., Ghatei M. A., et al. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab 2005; 90: 4521–4
   PubMed Web of Science ®Google Scholar
• Gormsen L. C., Gjedsted J., Gjedde S., Vestergaard E. T., Christiansen J. S., Jorgensen J. O., et al. Free fatty acids decrease circulating ghrelin concentrations in humans. Eur J Endocrinol 2006; 154: 667–73
   PubMed Web of Science ®Google Scholar
• Blom W. A., Lluch A., Vinoy S., Stafleu A., van den Berg R., Holst J. J., et al. Effects of gastric emptying on the postprandial ghrelin response. Am J Physiol Endocrinol Metab 2006; 290: E389–95
   PubMed Web of Science ®Google Scholar
• Batterham R. L., Cohen M. A., Ellis S. M., Le Roux C. W., Withers D. J., Frost G. S., et al. Inhibition of food intake in obese subjects by peptide YY3‐36. N Eng J Med 2003; 349: 941–8
   PubMed Web of Science ®Google Scholar
• Nagaya N., Uematsu M., Kojima M., Date Y., Nakazato M., Okumura H., et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 2001; 104: 2034–8
   PubMed Web of Science ®Google Scholar
• Shimizu Y., Nagaya N., Isobe T., Imazu M., Okumura H., Hosoda H., et al. Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res 2003; 9: 774–8
   PubMed Web of Science ®Google Scholar
• Otto B., Cuntz U., Fruehauf E., Wawarta R., Folwaczny C., Riepl R. L., et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2001; 145: 669–73
   PubMed Web of Science ®Google Scholar
• Espelund U., Hansen T. K., Hojlund K., Beck‐Nielsen H., Clausen J. T., Hansen B. S., et al. Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal‐weight subjects. J Clin Endocrinol Metab 2005; 90: 741–6
   PubMed Web of Science ®Google Scholar
• Hansen T. K., Dall R., Hosoda H., Kojima M., Kangawa K., Christiansen J. S., et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) 2002; 56: 203–06
   PubMed Web of Science ®Google Scholar
• Korbonits M., Blaine D., Elia M., Powell‐Tuck J. Refeeding Blaine: studies following a 44 day fast. N Eng J Med 2005; 353: 2307–08
   Google Scholar
• Broglio F., Koetsveld P. P., Benso A., Gottero C., Prodam F., Papotti M., et al. Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. J Clin Endocrinol Metab 2002; 87: 4829–32
   PubMed Web of Science ®Google Scholar
• Tan T. M., Vanderpump M., Khoo B., Patterson M., Ghatei M. A., Goldstone A. P. Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader‐Willi syndrome. J Clin Endocrinol Metab 2004; 89: 4162–5
   PubMed Web of Science ®Google Scholar
• Inui A. Cancer anorexia‐cachexia syndrome: current issues in research and management. CA Cancer J Clin 2002; 52: 72–91
   PubMed Web of Science ®Google Scholar
• Chung S. H., Lindholm B., Lee H. B. Is malnutrition an independent predictor of mortality in peritoneal dialysis patients?. Nephrol Dial Transplant 2003; 18: 2134–40
   PubMed Web of Science ®Google Scholar
• Tang A. M., Forrester J., Spiegelman D., Knox T. A., Tchetgen E., Gorbach S. L. Weight loss and survival in HIV‐positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31: 230–6
   PubMed Web of Science ®Google Scholar
• Nagaya N., Kojima M., Kangawa K. Ghrelin, a novel growth hormone‐releasing peptide, in the treatment of cardiopulmonary‐associated cachexia. Intern Med 2006; 45: 127–34
   PubMed Web of Science ®Google Scholar
• Neary N. M., Small C. J., Wren A. M., Lee J. L., Druce M. R., Palmieri C., et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo‐controlled trial. J Clin Endocrinol Metab 2004; 89: 2832–6
   PubMed Web of Science ®Google Scholar
• Wang W., Andersson M., Iresjo B. M., Lonnroth C., Lundholm K. Effects of ghrelin on anorexia in tumor‐bearing mice with eicosanoid‐related cachexia. Int J Oncol 2006; 28: 1393–400
   PubMed Web of Science ®Google Scholar
• Wynne K., Giannitsopoulou K., Small C. J., Patterson M., Frost G., Ghatei M. A., et al. Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo‐controlled trial. J Am Soc Nephrol 2005; 16: 2111–18
   PubMed Web of Science ®Google Scholar
• Nagaya N., Moriya J., Yasumura Y., Uematsu M., Ono F., Shimizu W., et al. Effects of Ghrelin Administration on Left Ventricular Function, Exercise Capacity, and Muscle Wasting in Patients With Chronic Heart Failure. Circulation 2004; 110: 3674–9
   PubMed Web of Science ®Google Scholar
• Nagaya N., Uematsu M., Kojima M., Ikeda Y., Yoshihara F., Shimizu W., et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001; 104: 1430–5
   PubMed Web of Science ®Google Scholar
• Nagaya N., Itoh T., Murakami S., Oya H., Uematsu M., Miyatake K., et al. Treatment of Cachexia With Ghrelin in Patients With COPD. Chest 2005; 128: 1187–93
   PubMed Web of Science ®Google Scholar
• Miljic D., Pekic S., Djurovic M., Doknic M., Milic N., Casanueva F., et al. Ghrelin has partial or no effect on appetite, growth hormone (GH), prolactin and cortisol release in patients with anorexia nervosa. J Clin Endocrinol Metab 2006; 91: 1491–5
   PubMed Web of Science ®Google Scholar
• Cummings D. E., Shannon M. H. Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss?. J Clin Endocrinol Metab 2003; 88: 2999–3002
   PubMed Web of Science ®Google Scholar
• Otto B., Tschop M., Fruhauf E., Heldwein W., Fichter M., Otto C., et al. Postprandial ghrelin release in anorectic patients before and after weight gain. Psychoneuroendocrinology 2005; 30: 577–81
   Google Scholar
• Trudel L., Tomasetto C., Rio M. C., Bouin M., Plourde V., Eberling P., et al. Ghrelin/motilin‐related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am J Physiol Gastrointest Liver Physiol 2002; 282: G948–52
   PubMed Web of Science ®Google Scholar
• Poitras P., Polvino W. J., Rocheleau B. Gastrokinetic effect of ghrelin analog RC‐1139 in the rat Effect on post‐operative and on morphine induced ileus. Peptides 2005; 26: 1598–601
   PubMed Web of Science ®Google Scholar
• De Winter B. Y., De Man J. G., Seerden T. C., Depoortere I., Herman A. G., Peeters T. L., et al. Effect of ghrelin and growth hormone‐releasing peptide 6 on septic ileus in mice. Neurogastroenterol Motil 2004; 16: 439–46
   PubMed Web of Science ®Google Scholar
• Murray C. D., Martin N. M., Patterson M., Taylor S., Ghatei M. A., Kamm M. A., et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double‐blind, placebo‐controlled, crossover study. Gut 2005; 54: 1693–8
   PubMed Web of Science ®Google Scholar
• Liu Y. L., Malik N. M., Sanger G. J., Andrews P. L. Ghrelin alleviates cancer chemotherapy‐associated dyspepsia in rodents. Cancer Chemother Pharmacol 2006; 58: 326–33
   PubMed Web of Science ®Google Scholar
• Kitazawa T., De Smet B., Verbeke K., Depoortere I., Peeters T. Gastric motor effects of peptide and non‐peptide ghrelin agonists in mice in vivo and in vitro. Gut 2005; 54: 1078–84
   PubMed Web of Science ®Google Scholar
• Le Roux C. W., Patterson M., Vincent R. P., Hunt C., Ghatei M. A., Bloom S. R. Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal‐weight but not obese subjects. J Clin Endocrinol Metab 2005; 90: 1068–71
   PubMed Web of Science ®Google Scholar
• Valera Mora M. E., Scarfone A., Valenza V., Calvani M., Greco A. V., Gasbarrini G., et al. Ghrelin does not influence gastric emptying in obese subjects. Obes Res 2005; 13: 739–44
   Google Scholar
• Pöykkö S. M., Kellokoski E., Horkko S., Kauma H., Kesaniemi Y. A., Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003; 52: 2546–53
   PubMed Web of Science ®Google Scholar
• McLaughlin T., Abbasi F., Lamendola C., Frayo R. S., Cummings D. E. Plasma ghrelin concentrations are decreased in insulin‐resistant obese adults relative to equally obese insulin‐sensitive controls. J Clin Endocrinol Metab 2004; 89: 1630–5
   PubMed Web of Science ®Google Scholar
• Purnell J. Q., Weigle D. S., Breen P. A., Cummings D. E. Ghrelin levels correlate with insulin levels, insulin resistance, and high‐density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab 2003; 88: 5747–52
   PubMed Web of Science ®Google Scholar
• Goldstone A. P., Thomas E. L., Brynes A. E., Castroman G., Edwards R., Ghatei M. A., et al. Elevated fasting plasma ghrelin in Prader‐Willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance. J Clin Endocrinol Metab 2004; 89: 1718–26
   PubMed Web of Science ®Google Scholar
• Ikezaki A., Hosoda H., Ito K., Iwama S., Miura N., Matsuoka H., et al. Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI‐1, but not with leptin, in obese children and adolescents. Diabetes 2002; 51: 3408–11
   PubMed Web of Science ®Google Scholar
• Bacha F., Arslanian S. A. Ghrelin suppression in overweight children: a manifestation of insulin resistance?. J Clin Endocrinol Metab 2005; 90: 2725–30
   PubMed Web of Science ®Google Scholar
• Anderwald C., Brabant G., Bernroider E., Horn R., Brehm A., Waldhausl W., et al. Insulin‐dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients. Diabetes 2003; 52: 1792–8
   PubMed Web of Science ®Google Scholar
• Masaoka T., Suzuki H., Hosoda H., Ota T., Minegishi Y., Nagata H., et al. Enhanced plasma ghrelin levels in rats with streptozotocin‐induced diabetes. FEBS Lett 2003; 541: 64–8
   PubMed Web of Science ®Google Scholar
• Ishii S., Kamegai J., Tamura H., Shimizu T., Sugihara H., Oikawa S. Role of ghrelin in streptozotocin‐induced diabetic hyperphagia. Endocrinology 2002; 143: 4934–7
   PubMed Web of Science ®Google Scholar
• Holdstock C., Ludvigsson J., Karlsson F. A. Abnormal ghrelin secretion in new onset childhood Type 1 diabetes. Diabetologia 2004; 47: 150–1
   Google Scholar
• Briatore L., Andraghetti G., Cordera R. Acute plasma glucose increase, but not early insulin response, regulates plasma ghrelin. Eur J Endocrinol 2003; 149: 403–06
   PubMedGoogle Scholar
• Soriano‐Guillen L., Barrios V., Lechuga‐Sancho A., Chowen J. A., Argente J. Response of circulating ghrelin levels to insulin therapy in children with newly diagnosed type 1 diabetes mellitus. Pediatr Res 2004; 55: 830–5
   Google Scholar
• Shiiya T., Nakazato M., Mizuta M., Date Y., Mondal M. S., Tanaka M., et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002; 87: 240–4
   PubMed Web of Science ®Google Scholar
• Goldstone A. P. Prader‐Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol Metab 2004; 15: 12–20
   PubMed Web of Science ®Google Scholar
• Goldstone A. P., Patterson M., Kalingag N., Ghatei M. A., Brynes A. E., Bloom S. R., et al. Fasting and postprandial hyperghrelinemia in Prader‐Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3‐36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. J Clin Endocrinol Metab 2005; 90: 2681–90
   PubMed Web of Science ®Google Scholar
• Cummings D. E., Clement K., Purnell J. Q., Vaisse C., Foster K. E., Frayo R. S., et al. Elevated plasma ghrelin levels in Prader‐Willi syndrome. Nat Med 2002; 8: 643–4
   PubMed Web of Science ®Google Scholar
• DelParigi A., Tschöp M., Heiman M. L., Salbe A. D., Vozarova B., Sell S. M., et al. High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader‐Willi syndrome. J Clin Endocrinol Metab 2002; 87: 5461–4
   PubMed Web of Science ®Google Scholar
• Aylwin S. J. Gastrointestinal surgery and gut hormones. Current Opinion In Endocrinology and Diabetes 2005; 12: 89–98
   Google Scholar
• Mariani L. M., Fusco A., Turriziani M., Veneziani A., Marini M. A., de Lorenzo A., et al. Transient increase of plasma ghrelin after laparoscopic adjustable gastric banding in morbid obesity. Horm Metab Res 2005; 37: 242–5
   PubMed Web of Science ®Google Scholar
• Stratis C., Alexandrides T., Vagenas K., Kalfarentzos F. Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with Roux‐en‐Y gastric bypass versus after colectomy: a prospective comparative study. Obes Surg 2006; 16: 752–8
   PubMed Web of Science ®Google Scholar
• Langer F. B., Reza Hoda M. A., Bohdjalian A., Felberbauer F. X., Zacherl J., Wenzl E., et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 2005; 15: 1024–9
   PubMed Web of Science ®Google Scholar
• Foschi D., Corsi F., Rizzi A., Asti E., Carsenzuola V., Vago T., et al. Vertical banded gastroplasty modifies plasma ghrelin secretion in obese patients. Obes Surg 2005; 15: 1129–32
   PubMed Web of Science ®Google Scholar
• Suzuki S., Ramos E. J., Goncalves C. G., Chen C., Meguid M. M. Changes in GI hormones and their effect on gastric emptying and transit times after Roux‐en‐Y gastric bypass in rat model. Surgery 2005; 138: 283–90
   PubMed Web of Science ®Google Scholar
• Stylopoulos N., Davis P., Pettit J. D., Rattner D. W., Kaplan L. M. Changes in serum ghrelin predict weight loss after Roux‐en‐Y gastric bypass in rats. Surg Endosc 2005; 19: 942–6
   Google Scholar
• Lin E., Gletsu N., Fugate K., McClusky D., Gu L. H., Zhu J. L., et al. The effects of gastric surgery on systemic ghrelin levels in the morbidly obese. Arch Surg 2004; 139: 780–4
   PubMedGoogle Scholar
• Borg C. M., Le Roux C. W., Ghatei M. A., Bloom S. R., Patel A. G., Aylwin S. J. Progressive rise in gut hormone levels after Roux‐en‐Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg 2006; 93: 210–15
   PubMed Web of Science ®Google Scholar
• Le Roux C. W., Aylwin S. J., Batterham R. L., Borg C. M., Coyle F., Prasad V., et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006; 243: 108–14
   PubMed Web of Science ®Google Scholar
• Korner J., Bessler M., Cirilo L. J., Conwell I. M., Daud A., Restuccia N. L., et al. Effects of Roux‐en‐Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 2005; 90: 359–65
   PubMed Web of Science ®Google Scholar
• Ram E., Vishne T., Diker D., Gal‐Ad I., Maayan R., Lerner I., et al. Impact of gastric banding on plasma ghrelin, growth hormone, cortisol, DHEA and DHEA‐S levels. Obes Surg 2005; 15: 1118–23
   Google Scholar